1. Home
  2. BCRX vs LU Comparison

BCRX vs LU Comparison

Compare BCRX & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • LU
  • Stock Information
  • Founded
  • BCRX 1986
  • LU 2005
  • Country
  • BCRX United States
  • LU China
  • Employees
  • BCRX N/A
  • LU N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • LU Finance: Consumer Services
  • Sector
  • BCRX Health Care
  • LU Finance
  • Exchange
  • BCRX Nasdaq
  • LU Nasdaq
  • Market Cap
  • BCRX 1.6B
  • LU 1.4B
  • IPO Year
  • BCRX 1994
  • LU 2020
  • Fundamental
  • Price
  • BCRX $7.95
  • LU $2.21
  • Analyst Decision
  • BCRX Buy
  • LU Hold
  • Analyst Count
  • BCRX 6
  • LU 2
  • Target Price
  • BCRX $14.17
  • LU $3.78
  • AVG Volume (30 Days)
  • BCRX 1.7M
  • LU 2.8M
  • Earning Date
  • BCRX 10-31-2024
  • LU 08-21-2024
  • Dividend Yield
  • BCRX N/A
  • LU 7.00%
  • EPS Growth
  • BCRX N/A
  • LU N/A
  • EPS
  • BCRX N/A
  • LU N/A
  • Revenue
  • BCRX $382,236,000.00
  • LU $4,854,013,946.00
  • Revenue This Year
  • BCRX $33.34
  • LU N/A
  • Revenue Next Year
  • BCRX $17.44
  • LU $6.67
  • P/E Ratio
  • BCRX N/A
  • LU N/A
  • Revenue Growth
  • BCRX 24.65
  • LU N/A
  • 52 Week Low
  • BCRX $4.03
  • LU $2.00
  • 52 Week High
  • BCRX $8.88
  • LU $4.94
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 51.57
  • LU 38.81
  • Support Level
  • BCRX $7.98
  • LU $2.13
  • Resistance Level
  • BCRX $8.88
  • LU $2.28
  • Average True Range (ATR)
  • BCRX 0.32
  • LU 0.07
  • MACD
  • BCRX -0.08
  • LU 0.01
  • Stochastic Oscillator
  • BCRX 29.32
  • LU 42.00

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About LU Lufax Holding Ltd each representing two (2)

Lufax Holding Ltd is a technology-empowered personal financial services platform in China. The company address the large unmet demand for personal lending among small business owners as well as salaried workers in China and provides tailor-made wealth management solutions to China's middle class and affluent population. Its platform has two hubs namely Retail Credit Facilitation Hub and Wealth Management Hub.

Share on Social Networks: